A machine learning-based model for predicting the risk of early-stage inguinal lymph node metastases in patients with squamous cell carcinoma of the penis
- PMID: 37009612
- PMCID: PMC10063794
- DOI: 10.3389/fsurg.2023.1095545
A machine learning-based model for predicting the risk of early-stage inguinal lymph node metastases in patients with squamous cell carcinoma of the penis
Abstract
Objective: Inguinal lymph node metastasis (ILNM) is significantly associated with poor prognosis in patients with squamous cell carcinoma of the penis (SCCP). Patient prognosis could be improved if the probability of ILNM incidence could be accurately predicted at an early stage. We developed a predictive model based on machine learning combined with big data to achieve this.
Methods: Data of patients diagnosed with SCCP were obtained from the Surveillance, Epidemiology, and End Results Program Research Data. By combing variables that represented the patients' clinical characteristics, we applied five machine learning algorithms to create predictive models based on logistic regression, eXtreme Gradient Boosting, Random Forest, Support Vector Machine, and k-Nearest Neighbor. Model performance was evaluated by ten-fold cross-validation receiver operating characteristic curves, which were used to calculate the area under the curve of the five models for predictive accuracy. Decision curve analysis was conducted to estimate the clinical utility of the models. An external validation cohort of 74 SCCP patients was selected from the Affiliated Hospital of Xuzhou Medical University (February 2008 to March 2021).
Results: A total of 1,056 patients with SCCP from the SEER database were enrolled as the training cohort, of which 164 (15.5%) developed early-stage ILNM. In the external validation cohort, 16.2% of patients developed early-stage ILNM. Multivariate logistic regression showed that tumor grade, inguinal lymph node dissection, radiotherapy, and chemotherapy were independent predictors of early-stage ILNM risk. The model based on the eXtreme Gradient Boosting algorithm showed stable and efficient prediction performance in both the training and external validation groups.
Conclusion: The ML model based on the XGB algorithm has high predictive effectiveness and may be used to predict early-stage ILNM risk in SCCP patients. Therefore, it may show promise in clinical decision-making.
Keywords: inguinal lymph node metastases; machine learning algorithms; penis cancer; prediction model; real-world research; squamous cell carcinoma.
© 2023 Ding, Zhang, Wang, Zhang, Wu, Xia, Li, Li and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
A Machine Learning Algorithm for Predicting the Risk of Developing to M1b Stage of Patients With Germ Cell Testicular Cancer.Front Public Health. 2022 Jun 29;10:916513. doi: 10.3389/fpubh.2022.916513. eCollection 2022. Front Public Health. 2022. PMID: 35844840 Free PMC article.
-
Development and validation of a machine learning model to predict the risk of lymph node metastasis in renal carcinoma.Front Endocrinol (Lausanne). 2022 Nov 18;13:1054358. doi: 10.3389/fendo.2022.1054358. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36465636 Free PMC article.
-
Machine Learning-Based Prediction of Lymph Node Metastasis Among Osteosarcoma Patients.Front Oncol. 2022 Apr 20;12:797103. doi: 10.3389/fonc.2022.797103. eCollection 2022. Front Oncol. 2022. PMID: 35515104 Free PMC article.
-
Model development and validation for predicting small-cell lung cancer bone metastasis utilizing diverse machine learning algorithms based on the SEER database.Medicine (Baltimore). 2025 Mar 21;104(12):e41987. doi: 10.1097/MD.0000000000041987. Medicine (Baltimore). 2025. PMID: 40128015 Free PMC article.
-
Application of Machine Learning Algorithms to Predict Central Lymph Node Metastasis in T1-T2, Non-invasive, and Clinically Node Negative Papillary Thyroid Carcinoma.Front Med (Lausanne). 2021 Mar 9;8:635771. doi: 10.3389/fmed.2021.635771. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33768105 Free PMC article.
Cited by
-
The Present and Future of Artificial Intelligence in Urological Cancer.J Clin Med. 2023 Jul 29;12(15):4995. doi: 10.3390/jcm12154995. J Clin Med. 2023. PMID: 37568397 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources